, , , , – 上海傲意

GENE

is a leading manufacturer of precision optical instruments and optical components in China. It is also the Chair of the Chinese Optical Instrument Committee and a constitutor of the International ISO Microscope standard.

OUR SERVICE

ABOUT GENE

GENE Optics is a leading manufacturer of precision optical instruments and optical components in China. It is also the Chair of the Chinese Optical Instrument Committee and a constitutor of the International ISO Microscope standard. The Company owns the brands “GENE”, “JIANGNAN”, and “NEXCOPE”.

Currently, we are also committed to the national project “Development and Industrialization of High-Resolution Fluorescence Microscopy”.Novel Optics has three production plants located in Ningbo, Nanjing and Zhenhai with a total of 1,200 employees.

FOUR PLATFORMS

HOT PRODUCT

OREHAB-ARM Smart Brace

OREHAB-ARM includes a training software system and a wearable light-weighted arm brace with multiple bio-sensors measuring elbow, shoulder movements. It's designed for post-stroke patient to have active and repetitive rehab exercises.

OREHAB-ARM Smart Brace

DIAGNOSTIC SERVICES

Digital polymerase chain reaction (dPCR) is a biotechnological refinement of conventional polymerase chain reaction methods that can be used to directly quantify and clonally amplify nucleic acids strands including DNA, cDNA, or RNA. The key difference between dPCR and traditional PCR lies in the method of measuring nucleic acids amounts, with the former being a more precise method than PCR.

DRUG R&D SERVICES

Combined with drug development needs, provide integrated solutions from clinical trial scheme consultation, patient recruitment, laboratory quality control molecular and immune biomarker detection services based on CAP, CLIA and ISO: 15189 certification, to final data mining.
Through gene big data, GENE helps drug research and development, provides professional testing services for early research and development and target screening of drug users, and provides ideas and strong support for new drug research and development verification

OUR ADVANTAGE

Qualitative/quantitative detection of infectious pathogenic microorganisms (especially low-copy microorganisms), detection of mutation in pathogen resistance gene, pathogen typing and identification.
OUR ADVANTAGE

Tumor/cancer-related gene variation (mutation, fusion, methylation, CNV, etc.) for early cancer screening, companion diagnosis, targeted drug therapy, treatment guidance,
OUR ADVANTAGE

Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.

MULTIGROUP RESEARCH

Qualitative/quantitative detection of infectious pathogenic microorganisms (especially low-copy microorganisms), detection of mutation in pathogen resistance gene, pathogen typing and identification.

SYNTHETIC BIOLOGY

Tumor/cancer-related gene variation (mutation, fusion, methylation, CNV, etc.) for early cancer screening, companion diagnosis, targeted drug therapy, treatment guidance, treatment efficacy monitoring and evaluation.

CELL THERAPY

Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.

MULTIGROUP RESEARCH

Qualitative/quantitative detection of infectious pathogenic microorganisms (especially low-copy microorganisms), detection of mutation in pathogen resistance gene, pathogen typing and identification.

SYNTHETIC BIOLOGY

CELL THERAPY

Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.

NEWS CENTER

NEOMA Business School Visits OYMotion Technologies in Shanghai…

In a world where globalization and innovation are the watchwords of the day, it is always a pleasure to receive in our facilities and share with key players of different industries but also the players of tomorrow.In this regard, this past month of June, we had the pleasure of hosting a distinguishe

05 August 2024

A Retrospective on Our Presence at OTWorld 2024

Last week marked the 2024 edition of the OTWorld international trade show in Leipzig, Germany, from May 14 to 17. OYMotion Technologies was thrilled to be part of this prestigious event, where we showcased our cutting-edge products and innovations, including the revolutionary bionic hand (the OHand™

27 May 2024

Introducing A New Category of Innovative Products: The Smart EEG Machine Series

In our relentless quest to provide the most intelligent solutions to individuals, based on our motto: “Technology Empowers Life”, we are thrilled to reveal our new innovative range of products: a series of smart Electroencephalogram (EEG) machines, which tackles the mysteries of the human brain and

11 May 2024

ABOUT GENE

FOUR PLATFORMS

HOT PRODUCT

DIAGNOSTIC SERVICES

DRUG R&D SERVICES

NEWS CENTER

QUICK LINKS

PRODUCT CATEGORY